Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hepion Pharmaceuticals Inc (NQ: HEPA )

0.7860 -0.0540 (-6.43%)
Streaming Delayed Price Updated: 3:57 PM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 373,272
Open 0.7600
Bid (Size) 0.7510 (87)
Ask (Size) 0.8200 (3)
Prev. Close 0.8400
Today's Range 0.7510 - 0.8400
52wk Range 0.7500 - 8.920
Shares Outstanding 5,472,451
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer
Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion at $58.5 million, and Pharma Two B plans... 
Via Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q1 2024
Hepion Pharmaceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-75.05%
-75.05%
1 Month
-26.54%
-26.54%
3 Month
-44.26%
-44.26%
6 Month
-62.39%
-62.39%
1 Year
-90.08%
-90.08%

More News

Read More
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Via Benzinga
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gold Falls Sharply; Matterport Shares Spike Higher
Via Benzinga
Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
HEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Tesla, Zoom, Hepion, Pfizer, ZIM: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment
Via Spotlight Growth
Topics Death
Exposures Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.